{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:49:00Z","timestamp":1786373340704,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.2215\/cjn.07290714","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T21:26:42Z","timestamp":1419629202000},"page":"443-451","source":"Crossref","is-referenced-by-count":36,"title":["Biomarkers of Kidney Injury and Klotho in Patients with Atherosclerotic Renovascular Disease"],"prefix":"10.2215","volume":"10","author":[{"given":"Moo Yong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Eirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Textor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230601","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00004872-200306000-00016","article-title":"Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization.","volume":"21","author":"Aqel","year":"2003","journal-title":"J Hypertens"},{"key":"R2-15-20230601","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/hr.2009.149","article-title":"Prevalence and predictors of renal artery stenosis in hypertensive patients undergoing coronary angiography.","volume":"32","author":"Ghaffari","year":"2009","journal-title":"Hypertens Res"},{"key":"R3-15-20230601","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00004872-199715120-00001","article-title":"Ischemic renal disease: An emerging cause of chronic renal failure and end-stage renal disease.","volume":"15","author":"Preston","year":"1997","journal-title":"J Hypertens"},{"key":"R4-15-20230601","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/16.4.765","article-title":"Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: Implications for renal functional outcome in atherosclerotic renovascular disease.","volume":"16","author":"Wright","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R5-15-20230601","doi-asserted-by":"crossref","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","article-title":"Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor.","volume":"8","author":"Zanchi","year":"2013","journal-title":"PLoS ONE"},{"key":"R6-15-20230601","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R7-15-20230601","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.109.134320","article-title":"Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage.","volume":"54","author":"Wang","year":"2009","journal-title":"Hypertension"},{"key":"R8-15-20230601","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1073\/pnas.0611079104","article-title":"Amelioration of progressive renal injury by genetic manipulation of Klotho gene.","volume":"104","author":"Haruna","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-15-20230601","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/ndt\/gfi165","article-title":"Klotho reduces apoptosis in experimental ischaemic acute renal failure.","volume":"20","author":"Sugiura","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R10-15-20230601","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1152\/physiolgenomics.00192.2009","article-title":"RNAi silencing of brain klotho potentiates cold-induced elevation of blood pressure via the endothelin pathway.","volume":"41","author":"Wang","year":"2010","journal-title":"Physiol Genomics"},{"key":"R11-15-20230601","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1998.8943","article-title":"Klotho protein protects against endothelial dysfunction.","volume":"248","author":"Saito","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-15-20230601","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23.","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"R13-15-20230601","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho.","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"R14-15-20230601","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.21.4.611","article-title":"Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study.","volume":"21","author":"Folsom","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-15-20230601","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI118626","article-title":"The urokinase receptor (CD87) facilitates CD11b\/CD18-mediated adhesion of human monocytes.","volume":"97","author":"Sitrin","year":"1996","journal-title":"J Clin Invest"},{"key":"R16-15-20230601","doi-asserted-by":"crossref","first-page":"29393","DOI":"10.1074\/jbc.271.46.29393","article-title":"Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.","volume":"271","author":"Yebra","year":"1996","journal-title":"J Biol Chem"},{"key":"R17-15-20230601","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s003950050157","article-title":"The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: Implications for cardiovascular function.","volume":"94","author":"Preissner","year":"1999","journal-title":"Basic Res Cardiol"},{"key":"R18-15-20230601","first-page":"331","article-title":"Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.","volume":"13","author":"Juhan-Vague","year":"1987","journal-title":"Diabete Metab"},{"key":"R19-15-20230601","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","article-title":"Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.","volume":"15","author":"Steins","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R20-15-20230601","first-page":"459","article-title":"Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis.","volume":"22","author":"Svensson","year":"2008","journal-title":"Int J Mol Med"},{"key":"R21-15-20230601","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","article-title":"Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.","volume":"216","author":"Sehestedt","year":"2011","journal-title":"Atherosclerosis"},{"key":"R22-15-20230601","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"R23-15-20230601","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","article-title":"A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.","volume":"85","author":"Wada","year":"2014","journal-title":"Kidney Int"},{"key":"R24-15-20230601","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis.","volume":"370","author":"Cooper","year":"2014","journal-title":"N Engl J Med"},{"key":"R25-15-20230601","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehs197","article-title":"Inflammatory and injury signals released from the post-stenotic human kidney.","volume":"34","author":"Eirin","year":"2013","journal-title":"Eur Heart J"},{"key":"R26-15-20230601","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCINTERVENTIONS.113.000219","article-title":"Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.","volume":"6","author":"Saad","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"R27-15-20230601","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiol.2432060655","article-title":"Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: Comparison with electron-beam CT.","volume":"243","author":"Daghini","year":"2007","journal-title":"Radiology"},{"key":"R28-15-20230601","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1242\/jcs.01149","article-title":"The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion.","volume":"117","author":"Furlan","year":"2004","journal-title":"J Cell Sci"},{"key":"R29-15-20230601","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.thromres.2007.10.017","article-title":"The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.","volume":"122","author":"Pawlak","year":"2008","journal-title":"Thromb Res"},{"key":"R30-15-20230601","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","article-title":"The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.","volume":"85","author":"Meijers","year":"2014","journal-title":"Kidney Int"},{"key":"R31-15-20230601","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor.","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"R32-15-20230601","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","article-title":"Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int"},{"key":"R33-15-20230601","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS.","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R34-15-20230601","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/01.ATV.0000097766.36623.DF","article-title":"Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.","volume":"23","author":"Schafer","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-15-20230601","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"key":"R36-15-20230601","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.","volume":"95","author":"Vaughan","year":"1995","journal-title":"J Clin Invest"},{"key":"R37-15-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.07.008","article-title":"Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: A randomized, double-blind, placebo-controlled study.","volume":"177","author":"Koh","year":"2004","journal-title":"Atherosclerosis"},{"key":"R38-15-20230601","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4161\/cam.22243","article-title":"VEGF-initiated angiogenesis and the uPA\/uPAR system.","volume":"6","author":"Breuss","year":"2012","journal-title":"Cell Adhes Migr"},{"key":"R39-15-20230601","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","article-title":"TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.","volume":"276","author":"Sakamoto","year":"1999","journal-title":"Am J Physiol"},{"key":"R40-15-20230601","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R41-15-20230601","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","article-title":"Regulation of fibroblast growth factor-23 in chronic kidney disease.","volume":"22","author":"Westerberg","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R42-15-20230601","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: A sequence suggested from a cross-sectional study.","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R43-15-20230601","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis.","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R44-15-20230601","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R45-15-20230601","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","article-title":"In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage.","volume":"39","author":"Mitani","year":"2002","journal-title":"Hypertension"},{"key":"R46-15-20230601","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/j.ajkd.2013.01.024","article-title":"Circulating \u03b1-klotho levels in CKD and relationship to progression.","volume":"61","author":"Kim","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R47-15-20230601","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.CIR.0000139854.74847.99","article-title":"Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse.","volume":"110","author":"Shimada","year":"2004","journal-title":"Circulation"},{"key":"R48-15-20230601","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1006\/bbrc.2000.3470","article-title":"In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome.","volume":"276","author":"Saito","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R49-15-20230601","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-2002-36699","article-title":"Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, \u201cKlotho\u201d mouse.","volume":"28","author":"Takeshita","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"R50-15-20230601","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/j.gastro.2009.12.002","article-title":"Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis.","volume":"138","author":"Thurston","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201503000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:58Z","timestamp":1786369498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201503000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07290714","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}